Neurocrine Biosciences, Inc. (NBIX)

Biotechnology

NBIX · NASDAQ NMS - GLOBAL MARKET · USD

New to investing? How to read this page →

$177.13

−1.88%

Watch Compare

Price · 1 year

Watch + Add to portfolio

Loading live analysis…

Loading analysis…

Intrinsic Investor is for education and research only — not financial advice.

Key metrics

EPS

$4.67

ROE

22.5%

Gross margin

64.4%

Debt/Equity

0.14x

Revenue growth

42.2%

Neurocrine Biosciences, Inc. — company intelligence

Earnings surprises

Q1 2026$1.91 vs $1.18 est+62.3%

Q4 2025$1.48 vs $1.92 est-22.9%

Q3 2025$2.04 vs $1.62 est+26.1%

Q2 2025$1.06 vs $0.99 est+7.0%

Analyst consensus · 37 analysts

32 Buy5 Hold0 Sell

Updated Jul 8, 2026

Insider activity · 90 days

12 buys15 sellsnet -286,673 shares

SHERWIN STEPHEN ASell 2,549 · Jun 5, 2026

SHERWIN STEPHEN ASell 1,843 · Jun 5, 2026

Onyia Judegift 2,441 · Jun 5, 2026

Recent SEC filings

4 — Insider transaction reportJul 9, 2026

4 — Insider transaction reportJun 30, 2026

4 — Insider transaction reportJun 9, 2026

Latest news

VRTX to Strengthen Rare Disease Portfolio With $10B Crinetics Buyout — Yahoo · 3d ago

RBC Capital Maintains Outperform on Neurocrine Biosciences, Raises Price Target to $195 — Benzinga · 3d ago

Reasons Why Investors Should Consider Betting on Neurocrine Stock — Yahoo · 4d ago

Neurocrine Biosciences Inc (NASDAQ:NBIX) Shines in the "Little Book That Makes You Rich" Screen — ChartMill · 1w ago

Neurocrine Biosciences: Why I Am Upholding A Buy Rating After M&A Deal For Soleno — SeekingAlpha · 1w ago

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Screen Stocks Learn Intrinsic Value Trading Signals Compare Stocks

Explore more

More in Biotechnology →More in Drug Manufacturers - Specialty & Generic →Stocks in US →Stocks on NASDAQ NMS - GLOBAL MARKET →Compare stocks side-by-side →

Peers & similar stocks

Quick links to related tickers for research.

AbbVie IncABBV Amgen Inc.AMGN Gilead Sciences, Inc.GILD Vertex Pharmaceuticals IncorporVRTX Regeneron Pharmaceuticals, Inc.REGN Revolution Medicines IncRVMD

About Neurocrine Biosciences, Inc.

Weekly undervalued picks (like NBIX)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.